U.S. CDC closes investigation on Abbott’s infant formula -Breaking
[ad_1]
© Reuters. FILE PHOTO: Abbott Laboratories emblem is displayed on a display screen on the New York Inventory Change (NYSE) in New York Metropolis, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Picture(Reuters) – The U.S. Facilities for Illness Management and Prevention (CDC) has closed its investigation on Abbott Laboratories (NYSE:)’ toddler formulation, with no further instances of infections, in keeping with a discover on the U.S. Meals and Drug Administration web site.
The businesses have been investigating bacterial infections brought on by the toddler formulation manufactured at Abbott’s Sturgis facility in Michigan.
[ad_2]